Table II.
Comparison of calculated and experimental mass with that identified from the 2D gel analysis
The calculated mass was obtained based on the amino acid sequence in GenBank™. The experimental mass was taken from the results of data from the literature and company data sheets.
| Protein | Calculated mass | Experimental mass | Mass on 2D gel |
|---|---|---|---|
| kDa | kDa | kDa | |
| Cytoskeleton and cytoskeleton-associated | |||
| Drebrin 1 isoform a | 71.9 | 116/125 | 125/132/134/131 |
| β-Actin | 42 | 42 | 46/32 |
| Spinophilin | 89.6 | 120–140 | 131 |
| α-Actinin-1 | 103 | 107 | 123 |
| α-Actinin-4 | 105 | 100–115 | 120, 123 |
| Capping protein α | 33 | 34 | 35 |
| Ezrin | 69.4 | 81 | 100 |
| Cofilin I | 18.7 | 19–21 | 13.25 |
| Glial fibrillary acidic protein | 49.5 | 50 | 47 |
| α-Tubulin | 50 | 57 | 75 |
| Signaling | |||
| 14-3-3ζ | 31 | 30 | 26/26/34/32/32/31 |
| 14-3-3ε | 28 | 31 | 30 |
| Inhibitor-2 of protein phosphatase 2A | 31–33 | 30 | 48/48/46 |
| Chaperones | |||
| Hsp90α | 85.1 | 90 | 113/111 |
| Heat shock protein gp96 precursor | 92.7, 90.3 | 100 | 125/122 |
| Valosin-containing protein | 90 | 97 | 118 |
| Protein translation and conjugation | |||
| Eukaryotic elongation factor 1γ | 50.5 | 46 | 58 |
| Metabolism | |||
| Inorganic pyrophosphatase | 33.1 | 33 | 35 |
| Glyceraldehyde-3-phosphate dehydrogenase | 36.2 | 38 | 36, 38 |
| Proteases | |||
| Neurolysin (EC 3.4.24.16) | 81.3 | 80 | 96 |
| Prolyl endopeptidase (prolyl oligopeptidase, EC 3.4.21.26) | 81.6 | 79.6 | 96 |
| Membrane and lipid binding | |||
| Rab GDP dissociation factor inhibitor α | 51 | 50 | 78 |
| Chain A, crystal structure of brain fatty acid-binding protein oleic acid | 14.8 | 13–14 | 11 |
| Annexin V | 35.8 | 38 | 38 |